MMM

MOLECURE

No trades
See on Supercharts
Market capitalization
‪244.12 M‬PLN
−1.18PLN
‪−18.31 M‬PLN
100.00PLN
‪11.57 M‬
Beta (1Y)
0.48

About MOLECURE

CEO
Marcin Jan Szumowski
Headquarters
Warsaw
Employees (FY)
111
Founded
2012
ISIN
PLONCTH00011
FIGI
BBG00K9D8XX0
Molecure SA engages in the discovery and development of small molecules for the treatment of unmet medical needs. It offers a platform of distinct small molecule programs targeting chitinases and chitinase-like-proteins, with potential utility in diverse inflammatory and fibrotic diseases. The company was founded by Stanislaw Wieslaw Pikul and Adam Golebiowski on March 12, 2012 and is headquartered in Warsaw, Poland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MOC is 14.70 PLN — it has decreased by 0.14% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange MOLECURE stocks are traded under the ticker MOC.
MOC stock is 0.96% volatile and has beta coefficient of 0.48. Check out the list of the most volatile stocks — is MOLECURE there?
MOLECURE revenue for the last quarter amounts to ‪200.00 K‬ PLN despite the estimated figure of ‪100.00 K‬ PLN. In the next quarter revenue is expected to reach ‪200.00 K‬ PLN.
Yes, you can track MOLECURE financials in yearly and quarterly reports right on TradingView.
MOC stock has fallen by 1.74% compared to the previous week, the month change is a 14.83% fall, over the last year MOLECURE has showed a 37.45% decrease.
MOC net income for the last quarter is ‪−6.80 M‬ PLN, while the quarter before that showed ‪−4.15 M‬ PLN of net income which accounts for −64.12% change. Track more MOLECURE financial stats to get the full picture.
Today MOLECURE has the market capitalization of ‪247.83 M‬, it has decreased by 5.08% over the last week.
No, MOC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MOC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOLECURE stock right from TradingView charts — choose your broker and connect to your account.
MOC reached its all-time high on Nov 9, 2020 with the price of 80.40 PLN, and its all-time low was 8.18 PLN and was reached on Mar 16, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 30, 2024, the company has 111.00 employees. See our rating of the largest employees — is MOLECURE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MOLECURE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MOLECURE stock shows the sell signal. See more of MOLECURE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MOLECURE future price: according to them, MOC price has a max estimate of 34.00 PLN and a min estimate of 34.00 PLN. Read a more detailed MOLECURE forecast: see what analysts think of MOLECURE and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MOLECURE EBITDA is ‪−20.96 M‬ PLN, and current EBITDA margin is ‪−20.69 M‬%. See more stats in MOLECURE financial statements.